pharma · Hepatitis B · Bacterial Infections
Green Valley Pharmaceutical
Green Valley (Shanghai) Pharmaceuticals Co.,
Green Valley Pharmaceutical clinical programs — 5 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Company details
- Status
- Public
- HQ
- New Jersey, USA
- Founded
- 1997
- Employees
- 111
- Programs
- 5
- Drugs
- 6
- Patents
- 0
Green Valley Pharmaceutical projects
5 ClinicalTrials.gov programs sponsored by Green Valley Pharmaceutical.
Green Valley Pharmaceutical has 5 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
-
GC1107
Green Valley (Shanghai) Pharmaceuticals Co.,
Bacterial Infections
1 trial -
Hyalobarrier
Green Valley (Shanghai) Pharmaceuticals Co.,
Thyroid Disease
1 trial -
Quadrivalent influenza vaccine
Green Valley (Shanghai) Pharmaceuticals Co.,
Influenza
1 trial -
GC1102
Green Valley (Shanghai) Pharmaceuticals Co.,
Hepatitis B
1 trial -
immunoglobulin G
Green Valley (Shanghai) Pharmaceuticals Co.,
Kawasaki Disease
1 trial
Frequently asked questions
How many clinical projects does Green Valley Pharmaceutical have?
5 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.